Literature DB >> 11959763

Pregnancy and oral contraceptive use do not significantly influence outcome in long term rheumatoid arthritis.

K W Drossaers-Bakker1, A H Zwinderman, D van Zeben, F C Breedveld, J M W Hazes.   

Abstract

BACKGROUND: Oral contraceptives (OC) and pregnancy are known to have an influence on the risk of onset of rheumatoid arthritis (RA). Pregnancy itself has beneficial effects on the activity of the disease, with relapses post partum. It is not known, however, whether OC and pregnancies influence the ultimate outcome of RA.
OBJECTIVES: To explore whether OC use and pregnancies influence the 12 year outcome in RA as measured by radiological damage and disability.
METHODS: In a prospective inception cohort of 132 female patients with recent RA according to the 1987 American College of Rheumatology criteria-a cohort initially gathered to study the association between hormonal factors and the onset of RA-outcome was assessed in a follow up after 12 years. The outcome was evaluated in 112 (85%) women by the radiological damage of hands and feet as measured with the Sharp score modification van der Heijde (SHS), the damage of the large joints measured with the Larsen score (LS) of large joints (0-60), and the disability measured with the Health Assessment Questionnaire (HAQ). The median values of each outcome variable were calculated for several subgroups of patients stratified for OC use and pregnancies before and after onset of the disease and the tertiles of the total number of months of OC use and of pregnancies. The association of OC use and pregnancies before and after onset of the disease with the outcome variables was calculated using Spearman's rank correlation (r(s)). The combined influence of OC use and pregnancies on the SHS, LS, and HAQ at 12 years was estimated using ordinal polytomous logistic regression.
RESULTS: The median values of the SHS, LS, and HAQ showed a trend towards less radiological joint damage and less disability in women with long term OC use and multiple pregnancies. This difference, however, was not significant, except for the HAQ score in women with three or more pregnancies in life. There was no association between pregnancies, however defined, and any parameter of RA outcome after 12 years (maximum r(s)=-0.10). The only significant correlation was found between OC use before symptom onset and the LS (r(s)=-0.22, p<0.05). The combination of hormonal variables explained no more than a maximum of 3% of the variance of the 12 year outcome as measured by the SHS.
CONCLUSION: OC use and pregnancy do not significantly influence outcome in long term RA. There is, however, a trend for patients with multiple pregnancies and long term OC use to have less radiographic joint damage and a better functional level.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959763      PMCID: PMC1754092          DOI: 10.1136/ard.61.5.405

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  20 in total

1.  Diminished incidence of severe rheumatoid arthritis associated with oral contraceptive use.

Authors:  D van Zeben; J M Hazes; J P Vandenbroucke; B A Dijkmans; A Cats
Journal:  Arthritis Rheum       Date:  1990-10

2.  Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.

Authors:  D M van der Heijde; M A van 't Hof; P L van Riel; L A Theunisse; E W Lubberts; M A van Leeuwen; M H van Rijswijk; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

3.  Timing of pregnancy in relation to the onset of rheumatoid arthritis.

Authors:  A Silman; A Kay; P Brennan
Journal:  Arthritis Rheum       Date:  1992-02

4.  Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors:  A Larsen; K Dale; M Eek
Journal:  Acta Radiol Diagn (Stockh)       Date:  1977-07

5.  Exogenous female hormones and rheumatoid arthritis: a methodological view of the contradictions in the literature.

Authors:  J M Esdaile
Journal:  Br J Rheumatol       Date:  1989

6.  Effect of oestrogen treatment on clinical and laboratory manifestations of rheumatoid arthritis.

Authors:  J W Bijlsma; O Huber-Bruning; J H Thijssen
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

Review 7.  The effects of gender and sex hormones on outcome in rheumatoid arthritis.

Authors:  J A Da Silva; G M Hall
Journal:  Baillieres Clin Rheumatol       Date:  1992-02

8.  The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytic epidemiological studies using meta-analysis.

Authors:  T D Spector; M C Hochberg
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

9.  Measurement of disability in Dutch rheumatoid arthritis patients.

Authors:  C E Siegert; L J Vleming; J P Vandenbroucke; A Cats
Journal:  Clin Rheumatol       Date:  1984-09       Impact factor: 2.980

10.  Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives.

Authors:  J M Hazes; B C Dijkmans; J P Vandenbroucke; R R de Vries; A Cats
Journal:  Arthritis Rheum       Date:  1990-02
View more
  10 in total

1.  Contraceptives, pregnancy, and RA.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

2.  Disease progression in relation to pre-onset parity among women with rheumatoid arthritis.

Authors:  Tiffany D Pan; Beth A Mueller; Carin E Dugowson; Michael L Richardson; J Lee Nelson
Journal:  Semin Arthritis Rheum       Date:  2019-06-18       Impact factor: 5.532

Review 3.  [Pregnancy in patients with rheumatoid arthritis and inflammatory spondylarthropathies].

Authors:  E Gromnica-Ihle; M Ostensen
Journal:  Z Rheumatol       Date:  2006-05       Impact factor: 1.372

4.  Non-contraceptive benefits of oral hormonal contraceptives.

Authors:  Adolf E Schindler
Journal:  Int J Endocrinol Metab       Date:  2012-12-21

5.  The relationship between post-onset pregnancy and functional outcome in women with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register.

Authors:  E M Camacho; T M Farragher; M Lunt; S M M Verstappen; D Bunn; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2010-06-25       Impact factor: 19.103

6.  Parity, time since last live birth and long-term functional outcome: a study of women participating in the Norfolk Arthritis Register.

Authors:  E M Camacho; M Harrison; T M Farragher; M Lunt; D K Bunn; S M M Verstappen; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2011-04       Impact factor: 19.103

7.  Identification of collagen-induced arthritis loci in aged multiparous female mice.

Authors:  Maria Liljander; Mary-Ann Sällström; Sara Andersson; Asa Andersson; Rikard Holmdahl; Ragnar Mattsson
Journal:  Arthritis Res Ther       Date:  2006-02-14       Impact factor: 5.156

Review 8.  Mechanisms of hypertension in autoimmune rheumatic diseases.

Authors:  Erin B Taylor; Victoria L Wolf; Elena Dent; Michael J Ryan
Journal:  Br J Pharmacol       Date:  2019-03-18       Impact factor: 8.739

9.  Early menopause and severity of rheumatoid arthritis in women older than 45 years.

Authors:  Mitra Pikwer; Jan-Åke Nilsson; Ulf Bergström; Lennart T H Jacobsson; Carl Turesson
Journal:  Arthritis Res Ther       Date:  2012-08-17       Impact factor: 5.156

10.  Parity influences the severity of ACPA-negative early rheumatoid arthritis: a cohort study based on the Swedish EIRA material.

Authors:  Mitra Pikwer; Cecilia Orellana; Henrik Källberg; Andreas Pikwer; Carl Turesson; Lars Klareskog; Lars Alfredsson; Saedis Saevarsdottir; Camilla Bengtsson
Journal:  Arthritis Res Ther       Date:  2015-12-12       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.